Literature DB >> 20393164

Incentives for drug development--the curious case of colchicine.

Aaron S Kesselheim1, Daniel H Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20393164     DOI： 10.1056/NEJMp1003126

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  19 in total

1.  Comment on: Generic and therapeutic substitution: a viewpoint on achieving best practice in Europe by Johnston et al.

Authors:  John B Warren; Kersti Oselin
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

2.  The rising prevalence and incidence of gout in British Columbia, Canada: Population-based trends from 2000 to 2012.

Authors:  Sharan K Rai; J Antonio Aviña-Zubieta; Natalie McCormick; Mary A De Vera; Kam Shojania; Eric C Sayre; Hyon K Choi
Journal:  Semin Arthritis Rheum       Date:  2016-08-17       Impact factor: 5.532

Review 3.  New sources of drugs for hematologic malignancies.

Authors:  Mahadeo A Sukhai; Paul A Spagnuolo; Scott Weir; James Kasper; Lavonne Patton; Aaron D Schimmer
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

Review 4.  Gout in 2010: progress and controversies in treatment.

Authors:  Nicola Dalbeth
Journal:  Nat Rev Rheumatol       Date:  2011-02       Impact factor: 20.543

Review 5.  Fair pricing of "old" orphan drugs: considerations for Canada's orphan drug policy.

Authors:  Eve A Roberts; Matthew Herder; Aidan Hollis
Journal:  CMAJ       Date:  2015-02-23       Impact factor: 8.262

6.  Interleukin-1 antagonism in acute gout: is targeting a single cytokine the answer?

Authors:  Tuhina Neogi
Journal:  Arthritis Rheum       Date:  2010-10

7.  The trientine crisis in Canada: a call to advocacy.

Authors:  Natasha Chandok; Eve A Roberts
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04

8.  Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.

Authors:  Aaron S Kesselheim; Jessica M Franklin; Seoyoung C Kim; John D Seeger; Daniel H Solomon
Journal:  J Gen Intern Med       Date:  2015-04-09       Impact factor: 5.128

Review 9.  Oral colchicine (Colcrys): in the treatment and prophylaxis of gout.

Authors:  Lily P H Yang
Journal:  Drugs       Date:  2010-08-20       Impact factor: 9.546

10.  The FDA and prescription pancreatic enzyme product cost.

Authors:  Timothy B Gardner; Jeffrey C Munson; Nancy E Morden
Journal:  Am J Gastroenterol       Date:  2014-05       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.